Clinical Trial: A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07635316) titled 'A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients' on May 22.

Brief Summary: This study aims to characterize current treatment patterns and clinical outcomes among newly diagnosed GEP-NET patients in the United States using open-source Longitudinal Prescription Claims (LRx) and Patient Centric Medical Claims (Dx) databases supplemented with mortality data.

Study Start Date: June 12

Study Type: OBSERVATIONAL

Condition: Gastroenteropancreatic Neuroendocrine Tumor

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Novartis Pharmaceuticals

Published by HT Digital Content Ser...